Andrew A. Hindman - Dec 2, 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, Chief Financial Officer
Signature
Brett A. Grimaud as Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Dec 2, 2021
Transactions value $
$0
Form type
4
Date filed
12/6/2021, 06:53 PM
Previous filing
Nov 23, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $0 +340K +203.28% $0.00 507K Dec 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 2, 2021, the reporting person was granted 340,000 RSUs. 240,000 RSUs are subject to service-based vesting conditions and the remaining 100,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.